Alistair Cook

Dr, BSc Aberd., PhD Edin.

Research Fellow, Health and Medical Sciences, Internal Medicine

https://orcid.org/0000-0001-5339-5374

Emailalistair.cook@uwa.edu.au

The University of Western Australia (M503), 35 Stirling Highway,
6009 Perth
Australia

Source: Scopus
Calculated using citation counts from Scopus for publications in the UWA Profiles and Research Repository

If you made any changes in Pure these will be visible here soon.

Personal profile

Industry keywords

Medicine and Pharma
Clinical Trials
Biotechnology

Research expertise keywords

Biomarkers
Flow cytometry
Mesothelioma
Cancer immunology
Immunotherapy

Fingerprint

Dive into the research topics where Alistair Cook is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

29 Similar Profiles

200 Citations
6 h-Index
9 Article
4 Review article
1 Chapter

Antiangiogeneic Strategies in Mesothelioma
Nowak, A. K., Brosseau, S., Cook, A. & Zalcman, G., 18 Feb 2020, In : Frontiers in Oncology. 10, 126.
Research output: Contribution to journal › Review article

Open Access
3 Citations (Scopus)
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
Nowak, A. K., Lesterhuis, W. J., Kok, P. S., Brown, C., Hughes, B. GM., Karikios, D. J., John, T., Kao, S. C. H., Leslie, C., Cook, A. M., Pavlakis, N., Briscoe, K., O'Byrne, K. J., Karapetis, C. S., Lam, W. S., Langford, A., Yip, S. & Stockler, M. R., Sep 2020, In : The Lancet Oncology. 21, 9, p. 1213-1223 11 p.
Research output: Contribution to journal › Article
6 Citations (Scopus)
Enhancing the efficacy of immunotherapy using radiotherapy
Keam, S., Gill, S., Ebert, M. A., Nowak, A. K. & Cook, A. M., 2020, In : Clinical and Translational Immunology. 9, 9, e1169.
Research output: Contribution to journal › Review article

Open Access
3 Citations (Scopus)
Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment
Aston, W. J., Hope, D. E., Cook, A. M., Boon, L., Dick, I., Nowak, A. K., Lake, R. A. & Lesterhuis, W. J., Jul 2019, In : OncoImmunology. 8 p.
Research output: Contribution to journal › Article

Open Access

2 Citations (Scopus)
Immune checkpoint inhibition for the treatment of mesothelioma
Nowak, A. K., McDonnell, A. & Cook, A., 2019, In : Expert Opinion on Biological Therapy. 19, 7, 10 p.
Research output: Contribution to journal › Review article

Open Access
File

9 Citations (Scopus)

336 Downloads (Pure)

2 Active
6 Finished

Dust Diseases Care Research Grant - Identifying biomarkers of response to chemo-immunotherapy in mesothelioma
Chee, J., Nowak, A., Lake, R., Cook, A. & Lesterhuis, W.
Insurance & Care NSW (icare)
1/01/21 → 31/12/23
Project: Research
Mixed radiotherapy fractionation: modulating tumour microenvironment to stimulate and enhance immunotherapy
Ebert, M., Cook, A., Nowak, A., Gill, S. & Jeraj, R.
Cancer Australia
1/05/19 → 30/04/22
Project: Research
Translational biomarkers of the DREAM study (a phase 2 trial of durvalumab with first line chemotherapy in mesothelioma with a safety run in
Nowak, A., Lesterhuis, W. & Cook, A.
AstraZeneca
1/07/19 → 30/06/20
Project: Research
Project Grant - Studying translational biomarkers from a positive clinical trial of chemoimmunotherapy
Nowak, A., Lesterhuis, W., Cook, A., Lassmann, T., Yip, S. & McDonnell, A.
Cancer Council Australia
1/01/19 → 30/06/20
Project: Research
DREAM predictive biomarkers
Nowak, A., Cook, A. & Lesterhuis, W.
Mesothelioma Applied Research Foundation
1/01/19 → 31/12/20
Project: Research